Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He's also NOT on the management team at PMCB.
Good luck with your strategy of buying when the pps collapses to .05. I hope it brings you riches.
Why, when the action today is between .09 and 0.98? waiting until .05 is for somebody who has faith that the company's value would increase from that point. Without a timeline from your hero Waggoner, the daily plays are the best plays with this scam.
I'm looking at .09
All of biotech is taking a thumping right now for some reason. Lots of good buying opportunities.
Exactly!
Was that Hidalgo I saw flipping burgers? Anyway, it's the investment community that lacks the faith, as evidence by the pps. You make it sound like Concordia and I are on an island and every other trader and investor has a positive opinion on PMCB. The proof is in the share price.
And I'm sure that .05 would instill confidence in so many investors that they'll rush out to buy at .05...or watch it go to .04. Nothing like negative momentum without a timeline to drive up the pps (sarcasm font).
You could not have bought it at .08 in the past few days...I think 0.87 was its low point unless I missed something.
Remember when the shareholder call was cut off because they only bought an hour's worth of conference call time? Has fly by night written all over it. Why would an investor take this company seriously? The only redeeming value of this stock is that it fluctuates enough to buy and sell, but since Waggoner's pps-killing press release, that price has now moved down 2 cents.
Care to rephrase that? -8% today.
A misleading PR or some kind of hype without a timeline. Or a bogus timeline. Take your pick.
Okay, you said you were buying today too. Is it still a loading zone if you buy 500,000 shares and the pps drops by 15%?
A whole 2.5 million?? Wow. They're flush. LOL
...or they have little money to pay their bills.
Without another pump, this baby is going to fall some more.
Can you define the loading zone? It seems to be a moving target.
Am not. As I have said dozens of times, nobody should be in a rush to get into this stock.
I was playing it between 0.10 (buy) and .109 (sell) for a while but there will be no pressure to get to .109.
Can somebody please define the loading zone?
Last week at 0.105, we were told it was a loading zone.
Then we were told that 0.10 was the loading zone.
Then when it fell to 0.998, that was the loading zone.
If you bought at any of these "loading zones," you'd be sorry today.
Hardly a ringing endorsement.
The previous BUY signal was issued on 03/15/2017, 2 days ago, when the stock price was 0.1010. Since then PMCB has fallen by -11.78%.
A sudden bearish attack caught us off guard without the forewarning of a bearish pattern. We may be on the verge of conceding THE DEATH OF BULLISH CASE and getting ready to cut our bullish bet. Our previous BUY signal didn't work out.
The American Association for Cancer Research is holding its annual meeting on April 1. I doubt that I'll be able to attend this year. The program is on line if anybody is interested in the latest research on novel treatments and delivery methods for pancreatic cancer or other forms of cancer. I did a search for pancreatic cancer and came up with about 200 hits.
http://www.abstractsonline.com/pp8/#!/4292/sessions/pancreatic/1
It's much more complicated than that. Sounds like they are looking for early signs of beta cell failure in individuals who may have a predisposition to type 1 diabetes. I'm glad they're getting funding...sounds promising.
No "other" diabetes treatment? Sorry, but PMCB doesn't have a diabetes treatment. It has a theoretical premise that remains to be proved, and that's about it.
We are fast approaching April 2017, and as many (including I) have predicted, a clinical trial is nowhere in sight.
Hmmm...unrealistic to expect a timeline when the company has been quoting dates for a clinical trial for 3 years, and misses all of those dates? How is it that other biotechs establish a timeline and adhere to them? Oh, those are REAL companies run by REAL CEOs and they have actual products that complete clinical trials.
His defensive rant is a sign of panic. The majority of shareholders are on to Waggoner's delay tactics, but a few paid shills still support him and implore everybody to "keep buying" because, you know, "it's a loading zone."
You might be buying high at .02. Maybe you should wait for .015.
Their reputations are on the clinical end. If they're recruited for compensation to conduct research and provide advice on clinical trials, and they perform as indicated, then their reputations aren't sullied by a company that can't hold up its end of the deal. But if you believe otherwise, then by all means, keep loading up on shares. Some people on this board claim they have owned shares for years and I can't imagine the losses they have (on paper), and if that isn't patience, then I don't know what is. Remember, clinical trials were supposed to start in 2016; we are near completion of the first quarter of 2017 and still not even a date as to when the trial will start. If you want to buy and hold for a decade while you pass up gains elsewhere, that's your right.
And if it's not "soon" investors know that they have no reason to invest, and the pps drops precipitously, and the company's value falls.
As a veteran of covering pharma and biotech, and as an investor in several of them, I can assure you that other companies do provide timelines to show their shareholders that they're making progress in the goals laid out for the company.
That's what happens when a fraud is CEO of the company. This baby is going to slide further. Hey, would that constitute another buying opportunity? Or would that be a loading zone?
What I read into it was the following: Don't expect a clinical trial to start anytime soon, if ever. And the investment community is acting accordingly. The share price will keep falling because investors see no reason to rush into buying into the company. Even the ones who are interested know that they can make money elsewhere until a clinical trial launches.
Remember when the clinical trial was supposed to launch in 2016?
No, you asked me if I was buying at .10, and I said, why buy at .10 when you know it's going to 0.95?
The same people who said it would never close below .12 and .11.
You're getting your wish today (and every day)!
Every day seems to be a buying opportunity for PMCB, according to some people on this board.
Buying opportunity, loading zone, take your pick of words.
"Watch and learn," according to one, as the pps shrinks even more.
Every day is a loading zone with PMCB!
A single digit close!
If you define "treating well" as making promises he doesn't keep and issuing pump and dump PRs, then by all means, the shareholders have been treated well.
...to see it fall later still. It seems like a sell order at just shy of 0.11 is the wise play.